Globus Medical (GMED) Tops Q1 EPS by 15c; rases guidance

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.72, $0.15 better than the analyst estimate of $0.57. Revenue for the quarter came in at $606.7 million versus the consensus estimate of $585.75 million.

GUIDANCE:

Globus Medical sees FY2024 EPS of $2.75-$2.85, versus the consensus of $2.69. Globus Medical sees FY2024 revenue of $2.46-2.485 billion, versus the consensus of $2.46 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO